SCHEMBL3850182

SCHEMBL3850182

c1ccc(CCN2CCN(c3ncnc4ccc(-c5cn[nH]c5)cc34)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.60
AKT1 P31749 1/20 0.53
ALDH1A1 P00352 8/20 0.51
MAPK1 P28482 6/20 0.51
LMNA P02545 6/20 0.51
HSD17B10 Q99714 3/20 0.51
POLB P06746 1/20 0.51
MAPT P10636 1/20 0.51
GRK2 P25098 1/20 0.48
GRK5 P34947 1/20 0.48
GRK1 Q15835 1/20 0.48
ABCB1 P08183 1/20 0.48
ABCC1 P33527 1/20 0.48
ABCG2 Q9UNQ0 1/20 0.48
CYP1A2 P05177 9/20 0.48
CYP3A4 P08684 9/20 0.48
CLK4 Q9HAZ1 7/20 0.48
CYP2D6 P10635 5/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3855452 0.90 AKT1 (0.54) AURKAAKT1ALDH1A1MAPK1LMNA
SCHEMBL3847360 0.90 ACHE (0.59) AURKAAKT1ALDH1A1MAPK1LMNA
Hydrochloric Acid SCHEMBL3851639 0.83 ACHE (0.54) AKT1ALDH1A1MAPK1LMNAHSD17B10
SCHEMBL3850109 0.82 CYP3A4 (0.65) AKT1ALDH1A1MAPK1LMNAHSD17B10
SCHEMBL3854867 0.82 AURKA (0.60) AURKAALDH1A1MAPK1LMNAHSD17B10
SCHEMBL30734227 0.80 ACHE (0.57) AKT1ALDH1A1MAPK1LMNAHSD17B10
SCHEMBL3854046 0.80 AKT1 (0.56) AKT1ALDH1A1MAPK1LMNAHSD17B10
SCHEMBL3854138 0.79 AKT1 (0.56) AURKAAKT1ALDH1A1MAPK1LMNA
SCHEMBL3848914 0.79 AKT1 (0.49) AKT1ALDH1A1MAPK1LMNAHSD17B10
SCHEMBL3846924 0.78 AKT1 (0.51) AURKAAKT1ALDH1A1MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed